Skip to main content
Fig. 4 | BMC Palliative Care

Fig. 4

From: Cost-effectiveness analysis of systematic fast-track transition from oncological treatment to specialised palliative care at home for patients and their caregivers: the DOMUS trial

Fig. 4

Cost-effectiveness acceptability curves for costs per QALY using different periods and with/without intervention costs. Note: The curves indicate the probability (y-axis) of DOMUS being cost-effective compared the usual care, given a specific threshold value (x-axis) for an additional QALY. Controlled for baseline utility Source: DOMUS trial data and administrative data from Statistic Denmark and the National eHealth Authority. EQORT for patients’ QALYs

Back to article page
\